Compare Biogen Inc (BIIB) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs Prospect Capital Corporation — how do they compare? Biogen Inc trades at $202.7 (market cap $30.13B), while Prospect Capital Corporation trades at $2.27 (market cap $1.14B). The key difference: Biogen Inc is far larger — about 26.4× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 21.93% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | PSEC | |
|---|---|---|
Market Cap | $30.13B | $1.14B |
Sector | Health | Financials |
52-Week High | $216.63 | $3.05 |
52-Week Low | $128.93 | $2.11 |
Enterprise Value | $37.20B | — |
Dividend Yield | — | 21.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
